Tin tức & Cập nhật
Lọc theo Chuyên ngành:

Antihypertensive drugs tied to HCC risk in MASLD with cirrhosis
Patients with metabolic dysfunction-associated steatotic liver disease (MASLD) and cirrhosis who are taking antihypertensive medications, including calcium channel blockers (CCBs) and angiotensin-converting enzyme inhibitors (ACEIs)/angiotensin receptor blockers (ARBs), are at increased risk of developing hepatocellular carcinoma (HCC), suggests a study.
Antihypertensive drugs tied to HCC risk in MASLD with cirrhosis
27 Nov 2024
Hypo-, hyperthyroidism causally linked to pre-eclampsia
Hyper- and hypothyroidism are causally associated with pre-eclampsia (PE), but PE does not causally influence thyroid dysfunctions, suggest the results of a Mendelian randomization (MR) study.
Hypo-, hyperthyroidism causally linked to pre-eclampsia
27 Nov 2024
14-day AF screening no better than usual care in stroke prevention
Use of a 14-day continuous electrocardiographic monitor to screen for atrial fibrillation (AF) in older adults seen in primary care practices does not seem to result in fewer hospitalizations for stroke when compared with usual care, reports a recent study.
14-day AF screening no better than usual care in stroke prevention
22 Nov 2024
ARBs a good alternative to ACEIs in patients with acute MI
The incidence of death is comparable between patients with acute myocardial infarction (MI) without heart failure (HF) receiving angiotensin II receptor blockers (ARBs) and those taking angiotensin-converting enzyme inhibitors (ACEIs), a study has shown.